Zobrazeno 1 - 10
of 12
pro vyhledávání: '"C L, Sawyers"'
Autor:
Fieke E. M. Froeling, David A. Tuveson, M. Zody, B. Hubert, Nicolas Robine, C. L. Sawyers, D. Oschwald, H. E. Varmus
Publikováno v:
Cancer Research. 79:5128-5128
Background and aims Recent advances in DNA sequencing technologies have revolutionized approaches to the prevention, risk assessment, early detection, diagnosis, and treatment of cancers. However, many ethnic groups, especially non-European populatio
Publikováno v:
Blood. 79:2089-2098
Existing in vitro culture technology does not permit the routine propagation of most human myeloid leukemias. Previous work has shown the usefulness of mice with severe combined immunodeficiency (SCID) for the growth of human lymphoblastic leukemia.
Autor:
N P, Shah, C L, Sawyers
Publikováno v:
Current opinion in investigational drugs (London, England : 2000). 2(3)
Autor:
C L, Sawyers
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 19
Publikováno v:
Cancer research. 61(16)
Androgen deprivation therapies for metastatic prostate cancer are useful initially, but progression to androgen independence usually results in relapse within 2 years. The molecular mechanisms underlying the clinically important transition from andro
Autor:
N, Craft, C, Chhor, C, Tran, A, Belldegrun, J, DeKernion, O N, Witte, J, Said, R E, Reiter, C L, Sawyers
Publikováno v:
Cancer research. 59(19)
Prostate cancers require androgen for growth but progress to an androgen-independent stage under the selective pressure of androgen ablation therapy. Here we describe a novel human prostate cancer xenograft (LAPC-9) propagated by serial passage in ma
Autor:
N, Craft, C L, Sawyers
Publikováno v:
Cancer metastasis reviews. 17(4)
Androgen blockade is the mainstay of therapy in the clinical management of advanced prostate cancer. Recent progress on two fronts--the development of newer xenograft and transgenic models and a greater understanding of nuclear receptor signaling--ha
Autor:
C L, Sawyers, B, Druker
Publikováno v:
The cancer journal from Scientific American. 5(2)
Autor:
C L, Sawyers
Publikováno v:
Bailliere's clinical haematology. 10(2)
BCR-ABL is an oncogenic fusion gene found in patients with chronic myelogenous leukaemia (CML) and acute lymphocytic leukaemia whose oncogenic potential has been demonstrated using in vitro and in vivo model systems. Current research efforts are focu
Publikováno v:
Oncogene. 11(4)
Growth suppression by the Rb and p53 tumor suppressor proteins is mediated through effects on cell cycle regulatory proteins at the G1/S transition. Because overexpression of c-Abl induces G1 arrest in fibroblasts, we reasoned that c-Abl may also aff